Deutsche Bank
DFTX

Deutsche Bank’s Definium Therapeutics DFTX Stock Holding History

Deutsche Bank’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.72M Sell
142,947
-268,887
-65% -$6.64M ﹤0.01% 1219
2026
Q1 		$7.78M Buy
411,834
+13,565
+3% +$230K ﹤0.01% 1135
2025
Q4 		$5.33M Buy
398,269
+343,109
+622% +$4.25M ﹤0.01% 1275
2025
Q3 		$650K Buy
55,160
+7,171
+15% +$66.9K ﹤0.01% 2417
2025
Q2 		$311K Sell
47,989
-11,237
-19% -$73.9K ﹤0.01% 2709
2025
Q1 		$346K Sell
59,226
-12,369
-17% -$88.6K ﹤0.01% 2676
2024
Q4 		$498K Buy
71,595
+24,716
+53% +$170K ﹤0.01% 2614
2024
Q3 		$267K Buy
46,879
+10,189
+28% +$70.9K ﹤0.01% 2775
2024
Q2 		$265K Buy
36,690
+31,077
+554% +$272K ﹤0.01% 2662
2024
Q1 		$52.8K Hold
5,613
– – ﹤0.01% 3382
2023
Q4 		$20.5K Hold
5,613
– – ﹤0.01% 3489
2023
Q3 		$17.6K Hold
5,613
– – ﹤0.01% 3518
2023
Q2 		$20K Sell
5,613
-2,408
-30% -$8.31K ﹤0.01% 3583
2023
Q1 		$25.4K Sell
8,021
-2,368
-23% -$7.87K ﹤0.01% 3686
2022
Q4 		$22.9K Hold
10,389
– – ﹤0.01% 3754
2022
Q3 		$37K Sell
10,389
-1,513
-13% -$14.5K ﹤0.01% 3667
2022
Q2 		$115K Sell
11,902
-12,517
-51% -$158K ﹤0.01% 3458
2022
Q1 		$406K Buy
24,419
+2,304
+10% +$40K ﹤0.01% 2873
2021
Q4 		$458K Buy
22,115
+1,140
+5% +$36.4K ﹤0.01% 2904
2021
Q3 		$732K Buy
20,975
+1,713
+9% +$74.1K ﹤0.01% 2805
2021
Q2 		$997K Buy
+19,262
New +$1.01M ﹤0.01% 2771

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Deutsche Bank's DFTX Position: Q2 2026 in Review

Deutsche Bank reduced its Definium Therapeutics (DFTX) stake by 65% in Q2 2026, selling an estimated $6.64M and leaving 142,947 shares worth $6.72M. The position accounts for ﹤0.01% of the portfolio, ranked #1219.

Deutsche Bank first reported a position in DFTX in Q2 2021 and has held it in 21 quarters since. The position peaked at $7.78M in Q1 2026. 361 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Deutsche Bank held 142,947 shares of Definium Therapeutics worth $6.72M as of Q2 2026.
  • Deutsche Bank sold 268,887 Definium Therapeutics shares in Q2 2026, an estimated $6.64M.
  • Definium Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1219 holding.
  • Deutsche Bank first reported a position in Definium Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • Deutsche Bank's Definium Therapeutics position peaked at $7.78M in Q1 2026.
  • 361 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.